Portable Monitoring Device for the Diagnosis of Sleep Apnea in Obese Patients
Validation of a Portable Monitoring System for the Diagnosis of Obstructive Sleep Apnea Syndrome in Patients With Level II and III Obesity
3 other identifiers
observational
40
1 country
1
Brief Summary
Introduction The portable monitoring system (PMS) recording of cardiopulmonary parameters (level III of ASDA) has been validated in subjects with high probability of Obstructive Sleep Apnea (OSA) without comorbidities. However, there is not any study evaluating this system when OSA is associated with morbid obesity, so the validation of PMS will be very useful in order to properly work-up this highly risk population. Objective: To evaluate the accuracy of level III type of PMS - Stardust™" (STD), on patients with level II and III of obesity and high clinical suspicion of OSA. Methods:Participants with BMI \> 35 kg/m2 and with suspicion of OSA will consecutively be selected from an Outpatients Sleep Clinic of UNIFESP. They will be randomized for the following order of recordings: 1\) STD at home for 1 night 2) STD in the sleep lab simultaneous to PSG. AHI will be taken for subsequent analysis:a) AHI PSG b) AHI STD -lab and c) AHI STD- home.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 15, 2011
CompletedFirst Posted
Study publicly available on registry
October 19, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedOctober 19, 2011
October 1, 2011
6 months
October 15, 2011
October 18, 2011
Conditions
Keywords
Study Arms (1)
Obese patients
BMI \> 35
Eligibility Criteria
Adults BMI \> 35 Male and female
You may qualify if:
- BMI \> 35
- Complaints of snoring, sleep apnea, daytime sleepiness
You may not qualify if:
- use of home oxygen
- other sleep diseases
- inability to perform PSG
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Associacao Fundo de Incentivo a Psicofarmacologia
São Paulo, São Paulo, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, associate professor
Study Record Dates
First Submitted
October 15, 2011
First Posted
October 19, 2011
Study Start
January 1, 2011
Primary Completion
July 1, 2011
Study Completion
January 1, 2012
Last Updated
October 19, 2011
Record last verified: 2011-10